Journal article
Concepts in US Food and Drug Administration Regulation of Artificial Intelligence for Medical Imaging
American journal of roentgenology (1976), Vol.213(4), pp.886-888
01 Oct 2019
PMID: 31166758
Abstract
OBJECTIVE. Although extensive attention has been focused on the enormous potential of artificial intelligence (AI) technology, a major question remains: how should this fundamentally new technology be regulated? The purpose of this article is to provide an overview of the pathways developed by the U.S. Food and Drug Administration to regulate the incorporation of AI in medical imaging.
CONCLUSION. AI is the new wave of innovation in health care. The technology holds promising applications to revolutionize all aspects of medicine.
Metrics
4 Record Views
Details
- Title
- Concepts in US Food and Drug Administration Regulation of Artificial Intelligence for Medical Imaging
- Creators
- Ajay Kohli - Hahnemann University HospitalVidur Mahajan - Institute of Genomics and Integrative BiologyKevin Seals - Univ Calif San Francisco, Dept Radiol, San Francisco, CA USAAjit Kohli - Oklahoma State University Medical CenterSaurabh Jha - Univ Penn Hlth Syst, Dept Radiol, Philadelphia, PA USA
- Publication Details
- American journal of roentgenology (1976), Vol.213(4), pp.886-888
- Publisher
- Amer Roentgen Ray Soc
- Number of pages
- 3
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiology (Radiologic Sciences)
- Web of Science ID
- WOS:000486611500035
- Scopus ID
- 2-s2.0-85072509171
- Other Identifier
- 991021860796604721
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Radiology, Nuclear Medicine & Medical Imaging